FORIAN INC (FORA) Fundamental Analysis & Valuation

NASDAQ:FORA • US34630N1063

Current stock price

2.06 USD
-0.02 (-0.96%)
Last:

This FORA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. FORA Profitability Analysis

1.1 Basic Checks

  • FORA had negative earnings in the past year.
  • FORA had a positive operating cash flow in the past year.
  • FORA had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: FORA reported negative operating cash flow in multiple years.
FORA Yearly Net Income VS EBIT VS OCF VS FCFFORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

  • The Return On Assets of FORA (-2.07%) is better than 62.86% of its industry peers.
  • With a decent Return On Equity value of -2.74%, FORA is doing good in the industry, outperforming 62.86% of the companies in the same industry.
Industry RankSector Rank
ROA -2.07%
ROE -2.74%
ROIC N/A
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
FORA Yearly ROA, ROE, ROICFORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • The Gross Margin of FORA (55.40%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of FORA has grown nicely.
  • FORA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
FORA Yearly Profit, Operating, Gross MarginsFORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. FORA Health Analysis

2.1 Basic Checks

  • FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FORA has more shares outstanding
  • FORA has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, FORA has an improved debt to assets ratio.
FORA Yearly Shares OutstandingFORA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
FORA Yearly Total Debt VS Total AssetsFORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • FORA has an Altman-Z score of 3.39. This indicates that FORA is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.39, FORA is doing good in the industry, outperforming 77.14% of the companies in the same industry.
  • There is no outstanding debt for FORA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.39
ROIC/WACCN/A
WACC9.4%
FORA Yearly LT Debt VS Equity VS FCFFORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • FORA has a Current Ratio of 3.87. This indicates that FORA is financially healthy and has no problem in meeting its short term obligations.
  • FORA has a better Current ratio (3.87) than 80.00% of its industry peers.
  • A Quick Ratio of 3.87 indicates that FORA has no problem at all paying its short term obligations.
  • The Quick ratio of FORA (3.87) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.87
FORA Yearly Current Assets VS Current LiabilitesFORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. FORA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 67.78% over the past year.
  • Looking at the last year, FORA shows a very strong growth in Revenue. The Revenue has grown by 42.60%.
  • The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)67.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)42.6%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%65.64%

3.2 Future

  • Based on estimates for the next years, FORA will show a very strong growth in Earnings Per Share. The EPS will grow by 66.28% on average per year.
  • The Revenue is expected to grow by 27.75% on average over the next years. This is a very strong growth
EPS Next Y159.5%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.19%
Revenue Next 2Y27.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FORA Yearly Revenue VS EstimatesFORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
FORA Yearly EPS VS EstimatesFORA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

4

4. FORA Valuation Analysis

4.1 Price/Earnings Ratio

  • FORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 22.44, the valuation of FORA can be described as rather expensive.
  • FORA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FORA is cheaper than 65.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.42, FORA is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 22.44
FORA Price Earnings VS Forward Price EarningsFORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

  • 62.86% of the companies in the same industry are more expensive than FORA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 45.27
EV/EBITDA N/A
FORA Per share dataFORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as FORA's earnings are expected to grow with 66.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FORA Dividend Analysis

5.1 Amount

  • FORA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FORA Fundamentals: All Metrics, Ratios and Statistics

FORIAN INC

NASDAQ:FORA (3/23/2026, 12:26:34 PM)

2.06

-0.02 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-20
Earnings (Next)05-12
Inst Owners12.85%
Inst Owner Change0.43%
Ins Owners43.04%
Ins Owner Change1.39%
Market Cap64.00M
Revenue(TTM)28.11M
Net Income(TTM)-852.60K
Analysts43.33
Price Target2.14 (3.88%)
Short Float %0.44%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-95.1%
Min EPS beat(2)-100%
Max EPS beat(2)-90.2%
EPS beat(4)1
Avg EPS beat(4)-22.06%
Min EPS beat(4)-100%
Max EPS beat(4)132.68%
EPS beat(8)3
Avg EPS beat(8)-22.3%
EPS beat(12)7
Avg EPS beat(12)37.03%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.53%
Min Revenue beat(2)2.29%
Max Revenue beat(2)4.76%
Revenue beat(4)4
Avg Revenue beat(4)10.54%
Min Revenue beat(4)2.29%
Max Revenue beat(4)28.95%
Revenue beat(8)4
Avg Revenue beat(8)1.85%
Revenue beat(12)6
Avg Revenue beat(12)0.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.44
P/S 2.28
P/FCF 45.27
P/OCF 45.27
P/B 2.06
P/tB 2.13
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0.09
Fwd EY4.46%
FCF(TTM)0.05
FCFY2.21%
OCF(TTM)0.05
OCFY2.21%
SpS0.9
BVpS1
TBVpS0.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.07%
ROE -2.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.4%
FCFM 5.03%
ROA(3y)-14.88%
ROA(5y)-26.21%
ROE(3y)-59.73%
ROE(5y)-65.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.06%
GM growth 5Y6.47%
F-Score7
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 3.87
Altman-Z 3.39
F-Score7
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)53.55%
Cap/Depr(5y)146.6%
Cap/Sales(3y)2.15%
Cap/Sales(5y)4.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y159.5%
EPS Next 2Y66.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)42.6%
Revenue growth 3Y6.09%
Revenue growth 5Y5.68%
Sales Q2Q%65.64%
Revenue Next Year52.19%
Revenue Next 2Y27.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-83.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3634.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.83%
OCF growth 3YN/A
OCF growth 5YN/A

FORIAN INC / FORA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FORIAN INC (FORA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FORA.


Can you provide the valuation status for FORIAN INC?

ChartMill assigns a valuation rating of 4 / 10 to FORIAN INC (FORA). This can be considered as Fairly Valued.


How profitable is FORIAN INC (FORA) stock?

FORIAN INC (FORA) has a profitability rating of 2 / 10.


What is the financial health of FORIAN INC (FORA) stock?

The financial health rating of FORIAN INC (FORA) is 8 / 10.